A national cancer clinical trials system for the 21st century : reinvigorating the NCI cooperative group program / Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Board on Health Care Services.

By:

Institute of Medicine (U.S.). Committee on Cancer Clinical Trials

Contributor(s):

Material type: Text

TextPublication details: Washington, D.C. : National Academies Press, 2010.Description: 1 online resource (xviii, 295 pages)Content type:

text

Media type:

computer

Carrier type:

online resource

ISBN:

9780309151870
0309151872
1282787438
9781282787438

Subject(s): Genre/Form:

Additional physical formats: Print version:: National cancer clinical trials system for the 21st century.DDC classification:

616.9940072 22

LOC classification:

R853.C55 N3 2010eb

NLM classification:

2010 L-844
QZ 266

Online resources:

Click here to access online

Contents:

Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials.

Summary: "The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description

Item type:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Home library	Collection	Call number	Materials specified	Status	Date due	Barcode
Electronic-Books	OPJGU Sonepat- Campus	E-Books EBSCO			Available

Includes bibliographical references.

Introduction -- The science of developing cancer therapy -- Operations, oversight, and funding of cancer clinical trials -- Physician and patient participation in cancer clinical trials.

"The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research."--Publisher's description

Print version record.

eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - Worldwide

There are no comments on this title.

to post a comment.